Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Description
Background: Opioid use disorder (OUD) continues to be major public health problem in the US and innovative medication strategies are needed. The extended-release injectable formulation of naltrexone (ER-NTX), an opioid receptor antagonist, is an